Risk of Death in Colorectal Cancer Patients with Multi-morbidities of Metabolic Syndrome: A Retrospective Multicohort Analysis

다국어 초록 (Multilingual Abstract)

Purpose The prevalence of multi-morbidities with colorectal cancer (CRC) is known to be increasing. Particularly prognosis of CRC patients co-diagnosed with metabolic syndrome (MetSyn) was largely unknown. We aimed to examine the death risk of CRC patients according to the multiple MetSyn morbidities.Materials and Methods We identified CRC patients with MetSyn from the electronic medical records (EMR) systems in five independent hospitals during 2006-2011. Information on deaths was jointly retrieved from EMR, cause of death registry and chronic disease surveillance as well as study-specific questionnaire. Cox proportional hazards regression was used to calculate the overall and CRC-specific hazards ratios (HR) comparing MetSyn CRC cohort with reference CRC cohort.Results A total of 682 CRC patients in MetSyn CRC cohort were identified from 24 months before CRC diagnosis to 1 month after. During a median follow-up of 92 months, we totally observed 584 deaths from CRC, 245 being in MetSyn cohort and 339 in reference cohort. Overall, MetSyn CRC cohort had an elevated risk of CRC-specific mortality (HR, 1.49; 95% confidence interval [CI], 1.07 to 1.90) and overall mortality (HR, 1.43; 95% CI, 1.09 to 1.84) compared to reference cohort after multiple adjustment. Stratified analyses showed higher mortality risk among women (HR, 1.87; 95% CI, 1.04 to 2.27) and specific components of MetSyn. Notably, the number of MetSyn components was observed to be significantly related to CRC prognosis.Conclusion Our findings supported that multi-morbidities of MetSyn associated with elevated death risk after CRC. MetSyn should be considered as an integrated medical condition more than its components in CRC prognostic management.

참고문헌 (Reference)

1 Center MM, "Worldwide variations in colorectal cancer" 59 : 366-378, 2009

2 Peeters PJ, "The risk of colorectal cancer in patients with type 2 diabetes : associations with treatment stage and obesity" 38 : 495-502, 2015

3 Alberti KG, "The metabolic syndrome : a new worldwide definition" 366 : 1059-1062, 2005

4 Braun S, "The link between the metabolic syndrome and cancer" 7 : 1003-1015, 2011

5 Peng F, "Preoperative metabolic syndrome and prognosis after radical resection for colorectal cancer : The Fujian prospective investigation of cancer(FIESTA)study" 139 : 2705-2713, 2016

6 Pelucchi C, "Metabolic syndrome is associated with colorectal cancer in men" 46 : 1866-1872, 2010

7 Mendonca FM, "Metabolic syndrome and risk of cancer:which link?" 64 : 182-189, 2015

8 Esposito K, "Metabolic syndrome and risk of cancer : a systematic review and meta-analysis" 35 : 2402-2411, 2012

9 Esposito K, "Metabolic syndrome and cancer: holistic or reductionist?" 45 : 362-364, 2014

10 Russo A, "Metabolic syndrome and cancer risk" 44 : 293-297, 2008

11 Ishino K, "Metabolic syndrome : a novel high-risk state for colorectal cancer" 334 : 56-61, 2013

12 Ulmer H, "Metabolic risk factors and cervical cancer in the metabolic syndrome and cancer project(Me-Can)" 125 : 330-335, 2012

13 Stocks T, "Metabolic factors and the risk of colorectal cancer in 580, 000 men and women in the metabolic syndrome and cancer project(Me-Can)" 117 : 2398-2407, 2011

14 Cespedes Feliciano EM, "Metabolic dysfunction, obesity, and survival among patients with early-stage colorectal cancer" 34 : 3664-3671, 2016

15 Norden A, "Letter: hypertension related to D.N.A. repair synthesis and carcinogen uptake" 2 : 1094-, 1975

16 Tie G, "Hypercholesterolemia increases colorectal cancer incidence by reducing production of NKT and gammadelta T cells from hematopoietic stem cells" 77 : 2351-2362, 2017

17 Bray F, "Global cancer statistics 2018 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries" 68 : 394-424, 2018

18 Vargas T, "Genes associated with metabolic syndrome predict disease-free survival in stage II colorectal cancer patients : a novel link between metabolic dysregulation and colorectal cancer" 8 : 1469-1481, 2014

19 Saetang J, "Diets link metabolic syndrome and colorectal cancer development(Review)" 37 : 1312-1320, 2017

20 Xue F, "Diabetes, metabolic syndrome, and breast cancer : a review of the current evidence" 86 : s823-35, 2007

21 Alberti KG, "Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation" 15 : 539-553, 1998

22 Grundy SM, "Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition" 109 : 433-438, 2004

23 Brenner H, "Colorectal cancer" 383 : 1490-1502, 2014

24 Ferlay J, "Cancer incidence and mortality worldwide : sources, methods and major patterns in GLOBOCAN 2012" 136 : E359-86, 2015

25 Stocks T, "Blood pressure and risk of cancer incidence and mortality in the Metabolic Syndrome and Cancer Project" 59 : 802-810, 2012

26 Marrero JA, "Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma" 42 : 218-224, 2005

27 Kabat GC, "A longitudinal study of the metabolic syndrome and risk of colorectal cancer in postmenopausal women" 21 : 326-332, 2012